Aiyaz Mohammed Musa Umarji, 48, pleaded guilty to importing $5 million of pseudoephedrine - a key ingredient to manufacture ...

Zealand Pharma CEO Adam Steensberg said Friday that the company is working on a next-generation weight loss drug that’s ...

XtalPi's AI biologics discovery platform, XtalFold, has been licensed to Janssen Biotech for advanced biotherapeutics ...

Zealand Pharma is working on the next-gen weight-loss treatment. Its Petrelintide showed promising results in a Phase 1b ...

Booster Therapeutics has announced its inception to develop a new class of proteasome activator medicines for ...

CNBC's Karen Gilchrist weighs in on Zealand Pharma's "next generation" obesity drug candidate and its search for a global ...

Zealand Pharma's CEO Adam Steensberg weighs in on early-stage trials of its obesity drug contender and talks down takeover ...

European markets are expected to open slightly higher on Friday as investors look ahead to highly anticipated fiscal stimulus ...

Danish biotech Zealand Pharma is targeting the “next generation” of weight loss drugs as competitors pile into a market ...